These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36621237)

  • 1. Erratum to: Tward, J; Lenz, L; Flake II, DD; Rajamani, S; Yonover, P; Olsson, C; Kapoor, DA; Mantz, C; Liauw, SL; Antic, T; Fabrizio, M; Salzstein, D; Shore, N; Albertson, D; Henderson, J; Lee, SP; Gay, HA; Michalski, J; Hung, A; Raben, D; Garraway, I; Lewis, MS; Nguyen, PL; Marshall, DT; Brawer, MK; Stone, S; Cohen, T. The clinical cell-cycle risk (CCR) score is associated with metastasis after radiation therapy and provides guidance on when to forgo combined androgen deprivation therapy with dose-escalated radiation. Int J Radiat Oncol Biol Phys 2022;113:66-76. doi.org/10.1016/j.ijrobp.2021.09.034.
    Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):543. PubMed ID: 36621237
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to: Jones, CU; Pugh, SL; Sandler, HM; Chetner, MP; Amin, MB; Bruner, DW; Zietman, AL; Den, RB; Leibenhaut, MH; Longo, JM; Bahary, JP; Rosenthal, SA; Souhami, L; Michalski, JM; Hartford, AC; Amin, PP; Roach, M 3rd; Yee, D; Efstathiou, JA; Rodgers, JP; Feng, FY; Shipley, WU. Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial. Int J Radiat Oncol Biol Phys 2022;112:294-303. doi: 10.1016/j.ijrobp.2021.08.031.
    Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):265. PubMed ID: 36526397
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum to: Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation Dose-Volume Effects in Radiation-Induced Rectal Injury. Int J Radiat Oncol Biol Phys 2010;76:S123-S129.
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1185. PubMed ID: 31327421
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to: Nguyen PL. Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2016;94:975-977.
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1549. PubMed ID: 27479731
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
    Gil M; Ramil F; AgÍs JA
    Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.
    Barnhart MK; Cartmill B; Ward EC; Brown E; Sim J; Saade G; Rayner S; Robinson RA; Simms VA; Smee RI
    Dysphagia; 2019 Dec; 34(6):869-878. PubMed ID: 30741335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum to: Kong X-T, Nguyen NT, Choi YJ, et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 2018;100:1195-1203.
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1289. PubMed ID: 30900570
    [No Abstract]   [Full Text] [Related]  

  • 8. Erratum to: Rice SL, Bale R, Breen DJ, de Baere T, Denys A, Guiu B, Goldberg N, Kim E, Lewandowski RJ, Helmberger T, Mejerjink M, Pereira PL, Solbiati L, Solomon SB, Sofocleous CT. The Management of Colorectal Cancer Liver Metastases: The Interventional Radiology Viewpoint. Int J Radiat Oncol Biol Phys 2019;103:537-539.
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1185. PubMed ID: 31071382
    [No Abstract]   [Full Text] [Related]  

  • 9. Erratum to: Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. Int J Radiat Oncol Biol Phys 2020;106:546-555.
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):390. PubMed ID: 32386739
    [No Abstract]   [Full Text] [Related]  

  • 10. The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.
    Tward J; Lenz L; Flake DD; Rajamani S; Yonover P; Olsson C; Kapoor DA; Mantz C; Liauw SL; Antic T; Fabrizio M; Salzstein D; Shore N; Albertson D; Henderson J; Lee SP; Gay HA; Michalski J; Hung A; Raben D; Garraway I; Lewis MS; Nguyen PL; Marshall DT; Brawer MK; Stone S; Cohen T
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):66-76. PubMed ID: 34610388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum to: Lee AW, Ng WT, Pan JJ, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:567-580.
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1166-1167. PubMed ID: 31748141
    [No Abstract]   [Full Text] [Related]  

  • 12. Erratum to: van der Velden JM, Peters M, Verlaan J-J, Versteeg AL, Zhang L, Tsao M, Danjoux C, Barnes E, van Vulpen M, Chow E, Verkooijen HM. Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases. Int J Radiat Oncol Biol Phys 2017;99:859-866.
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1186. PubMed ID: 31327423
    [No Abstract]   [Full Text] [Related]  

  • 13. In reply to Furweger et al. (Int J Radiat Oncol Biol Phys DOI: 10.1016/j.ijrobp.2009.11.030).
    Ma L; Sahgal A; Larson D
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1324; author reply 1324. PubMed ID: 22385727
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum to: Huang X-D, Li Y-C, Chen F-P, Zheng W-H, Zhou G-Q, Lin L, Hu J, He W-J, Zhang L-L, Kou J, Ma J, Zhang W-D, Qi Z-Y, and Sun Y. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:124-131.
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):651. PubMed ID: 32014155
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 16. In regard to Purdy JA, Michalski JM. Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer? Int J Radiat Oncol Biol Phys 2001;51:867-870.
    Levitt SH; Khan FM
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1085; author reply 1085-6. PubMed ID: 12095577
    [No Abstract]   [Full Text] [Related]  

  • 17. Erratum to: Li T-C, Liu C-C, Lee YZ, et al. Combination Therapy of Pulsed-Wave Ultrasound Hyperthermia and Immunostimulant OK-432 Enhances Systemic Antitumor Immunity for Cancer Treatment. Int J Radiat Oncol Biol Phys 2020; 108(1):140-149.
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):586. PubMed ID: 34473988
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Pollack A, Chinea FM, Bossart E, Kwon D, Abramowitz MC, Lynne C, Jorda M, Marples B, Patel VN, Wu XD, Reis I, Studenski MT, Casillas J, Stoyanova R. Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy. Int J Radiat Oncol Biol Phys 2020;107:305-315.
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):328. PubMed ID: 32819616
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum to: Cohen-Cutler S, Wong K, Mena V, et al. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy. Int J Radiat Oncol Biol Phys 2021:110(5);1488-1495.
    Cohen-Cutler S; Wong K; Mena V; Sianto K; Wright MA; Olch A; Orgel E
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):838-839. PubMed ID: 35101201
    [No Abstract]   [Full Text] [Related]  

  • 20. Erratum to: Melidis C, Bosch WR, Izewska J, et al. Global harmonization of quality assurance naming conventions in radiation therapy Clinical Trials. Int J Radiat Oncol Biol Phys 2014;90:1242-1249.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.